Credential Qtrade Securities Inc. Vertex Pharmaceuticals Inc Transaction History
Credential Qtrade Securities Inc.
- $1.86 Trillion
- Q1 2024
A detailed history of Credential Qtrade Securities Inc. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Credential Qtrade Securities Inc. holds 872 shares of VRTX stock, worth $409,534. This represents 0.02% of its overall portfolio holdings.
Number of Shares
872
Previous 1,060
17.74%
Holding current value
$409,534
Previous $431 Million
15.49%
% of portfolio
0.02%
Previous 0.03%
Shares
10 transactions
Others Institutions Holding VRTX
# of Institutions
1,827Shares Held
231MCall Options Held
1.38MPut Options Held
1.08M-
Capital World Investors Los Angeles, CA28.5MShares$13.4 Billion2.34% of portfolio
-
Vanguard Group Inc Valley Forge, PA23.5MShares$11 Billion0.21% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$10 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA14.5MShares$6.83 Billion1.6% of portfolio
-
State Street Corp Boston, MA11.8MShares$5.54 Billion0.24% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $121B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...